810 related articles for article (PubMed ID: 30563755)
1. IL-23 in inflammatory bowel diseases and colon cancer.
Neurath MF
Cytokine Growth Factor Rev; 2019 Feb; 45():1-8. PubMed ID: 30563755
[TBL] [Abstract][Full Text] [Related]
2. Lnc-ITSN1-2, Derived From RNA Sequencing, Correlates With Increased Disease Risk, Activity and Promotes CD4
Nie J; Zhao Q
Front Immunol; 2020; 11():852. PubMed ID: 32547537
[No Abstract] [Full Text] [Related]
3. Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease.
Shen W; Durum SK
Neurochem Res; 2010 Jun; 35(6):940-6. PubMed ID: 19915978
[TBL] [Abstract][Full Text] [Related]
4. Elevated IL-23R Expression and Foxp3+Rorgt+ Cells in Intestinal Mucosa During Acute and Chronic Colitis.
Yang J; Xu L
Med Sci Monit; 2016 Aug; 22():2785-92. PubMed ID: 27498708
[TBL] [Abstract][Full Text] [Related]
5. Immunopathogenesis of IBD: Batf as a Key Driver of Disease Activity.
Hildner K; Punkenburg E; Abendroth B; Neurath MF
Dig Dis; 2016; 34 Suppl 1():40-7. PubMed ID: 27548324
[TBL] [Abstract][Full Text] [Related]
6. Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease.
Cătană CS; Berindan Neagoe I; Cozma V; Magdaş C; Tăbăran F; Dumitraşcu DL
World J Gastroenterol; 2015 May; 21(19):5823-30. PubMed ID: 26019446
[TBL] [Abstract][Full Text] [Related]
7. Protective role of R381Q (rs11209026) polymorphism in IL-23R gene in immune-mediated diseases: A comprehensive review.
Abdollahi E; Tavasolian F; Momtazi-Borojeni AA; Samadi M; Rafatpanah H
J Immunotoxicol; 2016 May; 13(3):286-300. PubMed ID: 27043356
[TBL] [Abstract][Full Text] [Related]
8. Batf-dependent Th17 cells critically regulate IL-23 driven colitis-associated colon cancer.
Punkenburg E; Vogler T; Büttner M; Amann K; Waldner M; Atreya R; Abendroth B; Mudter J; Merkel S; Gallmeier E; Rose-John S; Neurath MF; Hildner K
Gut; 2016 Jul; 65(7):1139-50. PubMed ID: 25838550
[TBL] [Abstract][Full Text] [Related]
9. Natural killer T cells and ulcerative colitis.
Lai LJ; Shen J; Ran ZH
Cell Immunol; 2019 Jan; 335():1-5. PubMed ID: 30638678
[TBL] [Abstract][Full Text] [Related]
10. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
Seiderer J; Elben I; Diegelmann J; Glas J; Stallhofer J; Tillack C; Pfennig S; Jürgens M; Schmechel S; Konrad A; Göke B; Ochsenkühn T; Müller-Myhsok B; Lohse P; Brand S
Inflamm Bowel Dis; 2008 Apr; 14(4):437-45. PubMed ID: 18088064
[TBL] [Abstract][Full Text] [Related]
11. [Immunopathogenesis of inflammatory bowel diseases].
Neurath MF; Schürmann G
Chirurg; 2000 Jan; 71(1):30-40. PubMed ID: 10662999
[TBL] [Abstract][Full Text] [Related]
12. Total Glycosides of Peony Protects Against Inflammatory Bowel Disease by Regulating IL-23/IL-17 Axis and Th17/Treg Balance.
Li Q; Shan Q; Sang X; Zhu R; Chen X; Cao G
Am J Chin Med; 2019; 47(1):177-201. PubMed ID: 30612460
[TBL] [Abstract][Full Text] [Related]
13. Innate and adaptive immunity in inflammatory bowel disease.
Geremia A; Biancheri P; Allan P; Corazza GR; Di Sabatino A
Autoimmun Rev; 2014 Jan; 13(1):3-10. PubMed ID: 23774107
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease.
Xu XR; Liu CQ; Feng BS; Liu ZJ
World J Gastroenterol; 2014 Mar; 20(12):3255-64. PubMed ID: 24695798
[TBL] [Abstract][Full Text] [Related]
15. Delivery of IL-12p40 ameliorates DSS-induced colitis by suppressing IL-17A expression and inflammation in the intestinal mucosa.
Kim DJ; Kim KS; Song MY; Seo SH; Kim SJ; Yang BG; Jang MH; Sung YC
Clin Immunol; 2012 Sep; 144(3):190-9. PubMed ID: 22836084
[TBL] [Abstract][Full Text] [Related]
16. IL-36α expression is elevated in ulcerative colitis and promotes colonic inflammation.
Russell SE; Horan RM; Stefanska AM; Carey A; Leon G; Aguilera M; Statovci D; Moran T; Fallon PG; Shanahan F; Brint EK; Melgar S; Hussey S; Walsh PT
Mucosal Immunol; 2016 Sep; 9(5):1193-204. PubMed ID: 26813344
[TBL] [Abstract][Full Text] [Related]
17. The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity.
Liu Z; Yadav PK; Xu X; Su J; Chen C; Tang M; Lin H; Yu J; Qian J; Yang PC; Wang X
J Leukoc Biol; 2011 Apr; 89(4):597-606. PubMed ID: 21227898
[TBL] [Abstract][Full Text] [Related]
18. IL-23R+ innate lymphoid cells induce colitis via interleukin-22-dependent mechanism.
Eken A; Singh AK; Treuting PM; Oukka M
Mucosal Immunol; 2014 Jan; 7(1):143-54. PubMed ID: 23715173
[TBL] [Abstract][Full Text] [Related]
19. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
Cantor MJ; Nickerson P; Bernstein CN
Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590
[TBL] [Abstract][Full Text] [Related]
20. Treatment with IL-27 attenuates experimental colitis through the suppression of the development of IL-17-producing T helper cells.
Sasaoka T; Ito M; Yamashita J; Nakajima K; Tanaka I; Narita M; Hara Y; Hada K; Takahashi M; Ohno Y; Matsuo T; Kaneshiro Y; Tanaka H; Kaneko K
Am J Physiol Gastrointest Liver Physiol; 2011 Apr; 300(4):G568-76. PubMed ID: 21193526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
